cis-Clopidogrel-MPDerivative13CD3(Clopidogrel-MP-AM13CD3)是一种cis-Clopidogrel-MPDerivative氘代物。cis-Clopidogrel-MPDerivative(Clopidogrel-MP-AM)是Clopidogrel活性代谢产物的3'-甲氧基苯乙酮衍生物。Clopidogrel是一种具有口服活性血小板抑制剂，靶向P2Y12受体。
cis-Clopidogrel-MP Derivative 13CD3 (Clopidogrel-MP-AM 13CD3) is a deuterium labele cis-Clopidogrel-MP Derivative. cis-Clopidogrel-MP Derivative is a 3'-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor[2].
[1]. Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48(4):1219-24. [2]. Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan.
动态评分
0.0